Company news
Oncolytics Biotech Inc. news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Oncolytics Biotech® Inc. Announces Presentation of REOLYSIN® Preclinical Research at the 2016 ASGCT Annual Meeting
May 5, 2016
Oncolytics Biotech® Inc. Announces Details of 2016 Annual Meeting of Shareholders
May 3, 2016
Oncolytics Biotech® Inc. to Participate in the Bloom Burton & Co. Healthcare Investor Conference
April 29, 2016
Oncolytics Biotech® Inc. Announces Formation of Science and Technology Committee
April 29, 2016
Oncolytics Biotech® Inc. Collaborators Present REOLYSIN® Preclinical Research at the 2016 AACR Annual Meeting
April 18, 2016
Oncolytics Biotech® Inc. Reports Updated Data from Randomized Phase 2 Study of REOLYSIN® in Pancreatic Cancer
April 14, 2016
Oncolytics Biotech® Inc. Announces Filing of Management Information Circular and Details of 2016 Annual General Meeting
March 24, 2016
Calls
The 5 newest of 16 calls. Every call is listed under its year.
- Oncolytics Biotech (NASDAQ:ONCY) Q2 2025 Earnings Call
Aug 7, 2025
Transcript - Oncolytics Biotech (NASDAQ:ONCY) Q1 2025 Earnings Call
May 14, 2025
Transcript - Oncolytics Biotech (NASDAQ:ONCY) Q4 2024 Earnings Call
Mar 7, 2025
Transcript - Oncolytics Biotech (NASDAQ:ONCY) Q3 2024 Earnings Call
Nov 12, 2024
Transcript - Oncolytics Biotech (NASDAQ:ONCY) Q2 2024 Earnings Call
Aug 1, 2024
Transcript
Decks
The 5 newest of 22 decks. Every deck is listed under its year.
- Investor Presentation (August 2026)
Investor deck · 27 slides · August 2026
- Investor Presentation (June 2026)
Investor deck · 27 slides · June 2026
- Investor Presentation (April 2026)
Investor deck · 26 slides · April 2026
- Investor Presentation (March 2026)
Investor deck · 23 slides · March 2026
- Investor Presentation (October 2025)
Investor deck · 21 slides · Oct 10, 2025